dQ&A launched the beta of our next-gen AI Insights Platform—a breakthrough natural language solution providing instant, data-driven answers for the diabetes market.
From a son’s T1D diagnosis to thousands of focus groups and ethnographies, discover the journey behind dQ&A’s qualitative insights service.
Our quarterly U.S. survey shows diabetes sharply reduces productivity and daily-life capacity—evidence that employers must offer stronger support.
Our research explores the connection between time-in-range and mental health in people with type 1 and type 2 diabetes.
Since day one, dQ&A has elevated diabetes patient voices—explore our infographic to see how these insights have shaped client decisions over the years.
Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.
Erik Shoger presented real-world patient insights at the FDA advisory meeting on sotagliflozin, highlighting the need for education and training if approved.
We invite you to watch this 4-minute selfie video reel featuring real people describing their very real struggles with diabetes.
Our quarterly U.S. diabetes survey found one-third of respondents had mild or severe depression, underscoring the need for more support and better treatments.
